| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 2.13 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Apigenin, a poten t na tural flav onoid , has emerged as a key therapeutic agent due to its multifac et ed medicinal properties in combating various diseases. How ev er, apigenin’s clinical utility is greatly limited by its poor w a ter solubility, low bioav ailabilit y and stabilit y issues. To address these challenges, this review paper explores the innov a tive field of nanotechnology-based delivery sy st ems, which have shown significant promise in improving the delivery and effectiveness of apigenin. This paper also explores the synerg istic pot ential of c o-delivering apigenin with conventional therapeutic agents. Despite the advantageous properties of these nanoformulations, critical challenges such as scalable pr oduction, r egulatory appr ovals and compr ehensiv e long-term safety assessments remain key hurdles in their clinical adoption which must be addressed for commercialization of apigenin-based formulations.
Descrição
Palavras-chave
Apigenin Bioavailability Flavonoid Nanocarriers Polymers Stability Therapeutics
Contexto Educativo
Citação
Editora
Informa UK Limited
Licença CC
Sem licença CC
